[HTML][HTML] Impact of mepolizumab on exacerbations in severe asthma: results from a US insurance claims data base
H Ortega, B Hahn, M Bogart, CF Bell… - Allergy and Asthma …, 2020 - ingentaconnect.com
Background: In controlled clinical studies, mepolizumab has been shown to reduce
exacerbation rates and the use of oral corticosteroids as well as improve asthma control and …
exacerbation rates and the use of oral corticosteroids as well as improve asthma control and …
Impact of mepolizumab on exacerbations in severe asthma: Results from a US insurance claims data base.
H Ortega, B Hahn, M Bogart, CF Bell… - Allergy and Asthma …, 2020 - europepmc.org
Background: In controlled clinical studies, mepolizumab has been shown to reduce
exacerbation rates and the use of oral corticosteroids as well as improve asthma control and …
exacerbation rates and the use of oral corticosteroids as well as improve asthma control and …
Impact of mepolizumab on exacerbations in severe asthma: Results from a US insurance claims data base.
H Ortega, B Hahn, M Bogart, CF Bell… - Allergy & Asthma …, 2020 - search.ebscohost.com
Background: In controlled clinical studies, mepolizumab has been shown to reduce
exacerbation rates and the use of oral corticosteroids as well as improve asthma control and …
exacerbation rates and the use of oral corticosteroids as well as improve asthma control and …
Impact of mepolizumab on exacerbations in severe asthma: Results from a US insurance claims data base
H Ortega, B Hahn, M Bogart, CF Bell… - Allergy and Asthma …, 2020 - cir.nii.ac.jp
抄録< jats: p>< jats: bold> Background:</jats: bold> In controlled clinical studies,
mepolizumab has been shown to reduce exacerbation rates and the use of oral …
mepolizumab has been shown to reduce exacerbation rates and the use of oral …
Impact of mepolizumab on exacerbations in severe asthma: Results from a US insurance claims data base
H Ortega, B Hahn, M Bogart, CF Bell… - Allergy and asthma …, 2020 - pubmed.ncbi.nlm.nih.gov
Background: In controlled clinical studies, mepolizumab has been shown to reduce
exacerbation rates and the use of oral corticosteroids as well as improve asthma control and …
exacerbation rates and the use of oral corticosteroids as well as improve asthma control and …